Asthma Risk Up Slightly for Planned C-Section Children

Share this content:
Asthma Risk Up Slightly for Planned C-Section Children
Asthma Risk Up Slightly for Planned C-Section Children

WEDNESDAY, Dec. 2, 2015 (HealthDay News) -- Children born by planned cesarean delivery appear to have slightly higher odds of developing asthma than those born through vaginal delivery, researchers report in the Dec. 1 issue of the Journal of the American Medical Association.

Mairead Black, M.B.Ch.B., a clinical lecturer and research fellow in obstetrics at the University of Aberdeen in the United Kingdom, and colleagues collected data on 321,287 firstborns in Scotland between 1993 and 2007, and followed them until February 2015. The investigators found that, compared with children born by vaginal delivery, those born by planned cesarean delivery were at increased risk for asthma requiring hospitalization (adjusted hazard ratio [aHR], 1.22), asthma inhaler prescription at age 5 (aHR, 1.13), and death (aHR, 1.41). There were no increased risks noted for obesity at age 5, inflammatory bowel disease, type 1 diabetes, or cancer.

Another study in the same journal looked at cesarean delivery rates around the world, and found higher cesarean rates correlated with lower mortality rates among infants and new mothers. The rates of cesarean delivery vary widely from country to country, from as low as 2 percent to more than 50 percent, the researchers found.

"In countries that provide very low rates of C-sections, there are very high rates of maternal and neonatal deaths," lead researcher Thomas Weiser, M.D., M.P.H., an assistant professor of surgery at the Stanford University School of Medicine in California, told HealthDay. As the number of C-sections increases, the rates of maternal and neonatal deaths decrease, he said. But when the rate of C-sections reaches about 19 per 100 births, there are no further reductions in deaths, Weiser added.

Abstract 1
Full Text (subscription or payment may be required)
Abstract 2
Full Text
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »